# Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De)

> **NCT02620332** · PHASE1 · COMPLETED · sponsor: **King's College London** · enrollment: 27 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** MultiPepT1De injection
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02620332
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-20
- **Primary completion:** 2017-07-31
- **Final completion:** 2018-04-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2019-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02620332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02620332, "Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02620332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*